Methods and immune modulatory nucleic acid compositions for preventing and treating disease

Details for Australian Patent Application No. 2003294400 (hide)

Owner Bayhill Therapeutics, Inc. The Board of Trustees of The Leland Stanford Junior University

Inventors Ho, Peggy P.; Garren, Hideki; Steinman, Lawrence

Agent FB Rice

Pub. Number AU-B-2003294400

PCT Number PCT/US2003/0371

PCT Pub. Number WO2004/047734

Priority 60/428,643 21.11.02 US

Filing date 21 November 2003

Wipo publication date 18 June 2004

Acceptance publication date 18 December 2008

International Classifications

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61K 31/70 (2006.01) - Carbohydrates

A61K 31/715 (2006.01) - Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages

Event Publications

22 April 2004 Complete Application Filed

  Priority application(s): 60/428,643 21.11.02 US

22 July 2004 Application Open to Public Inspection

  Published as AU-B-2003294400

7 July 2005 Amendment Made

  The nature of the amendment is: Amend the name of the applicant from The Board of Trustees of The Leland Stanford University to The Board of Trustees of The Leland Stanford Junior University

18 December 2008 Application Accepted

  Published as AU-B-2003294400

23 April 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003294401-Broad spectrum anti-viral therapeutics and prophylaxis

2003294399-MODULATION OF PROTEINS BY PHENOLIC COMPOUDNS